Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Using brain signals to control devices for movement and speech

Official title: A High-Performance ECoG-based Neural Interface for Communication and Neuroprosthetic Control

Run by University of California, San Francisco · NCT03698149 · Data updated 2026-11-12

This study is testing if people with severe neurological disorders can use brain signals to control devices that help them move and speak better.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment3 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedNovember 9, 2018
Main results expectedAugust 15, 2030
Study endsAugust 15, 2030
Registry record updatedMay 5, 2026
Trial IDNCT03698149 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 21 with limited upper limb mobility due to conditions like ALS, spinal cord injury, or stroke, and who have a significant loss of independence.

Probably not a fit

Patients who are pregnant, unable to understand English, or have severe psychiatric conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the feasibility of using electrocorticography (ECoG) signals to enable adults with severe neurological disorders to control complex devices for motor and speech functions. Participants will have electrodes placed on the surface of their brains to record electrical activity, which will be used to train them in controlling a robotic system. The study aims to assess whether these brain signals can facilitate speech production, providing a new avenue for communication and mobility for affected individuals.

Why it matters

Potential benefit: If successful, this approach could significantly enhance the quality of life for patients with severe neurological impairments by restoring their ability to communicate and control devices.

How similar studies have gone: Other studies using ECoG for motor and speech control have shown promise, indicating that this approach is both innovative and grounded in prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age \> 21
2. Limited ability to use upper limbs, based on neurological examination, due to stroke, amyotrophic lateral sclerosis (ALS), multiple sclerosis, cervical spinal cord injury, brainstem stroke, muscular dystrophy, myopathy or severe neuropathy.
3. Disability, defined by a 4 or greater score on the Modified Rankin Scale, must be severe enough to cause loss of independence and inability to perform activities of daily living.
4. If stroke or spinal cord injury, at least 1 year has passed since onset of symptoms
5. Must live within a two-hour drive of UCSF

Exclusion Criteria:

1. Pregnancy or breastfeeding
2. Inability to understand and/or read English
3. Inability to give consent
4. Dementia, based on history, physical exam, and MMSE
5. Active depression (BDI \> 20) or other psychiatric illness (active general anxiety disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder (OCD), or personality disorders (e.g. multiple personality disorder, borderline personality disorder, etc.)
6. History of suicide attempt or suicidal ideation
7. History of substance abuse
8. Co-morbidities including ongoing anticoagulation, uncontrolled hypertension, cancer, or major organ system failure
9. Inability to comply with study follow-up visits
10. Any prior intracranial surgery
11. History of seizures
12. Immunocompromised
13. Has an active infection
14. Has a CSF drainage system or an active CSF leak
15. Requires diathermy, electroconvulsive therapy (ECT), or transcranial magnetic stimulation (TMS) to treat a chronic condition
16. Has an implanted electronic device such as a neurostimulator, cardiac pacemaker/defibrillator or medication pump, or presence of any head or neck metallic foreign bodies
17. Allergies or known hypersensitivity to materials in the Blackrock NeuroPort Array (i.e. silicone, titanium) or the PMT Subdural Cortical Electrode (silicone, platinum iridium, nichrome)

Where it's running

  • University of California San Francisco
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Karunesh Ganguly, MD, PhD — University of California, San Francisco
  • Study coordinator: Adelyn Tu-Chan
  • Email: adelyn.tu@ucsf.edu
  • Phone: (415) 575-0431

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.